International Journal of Health and Clinical Research

International Journal of Health and Clinical Research

C-KIT expression in breast carcinoma and its correlation with TNM stage, grade and expression of ER, PR, HER2/NEU& BRCA1

Yazarlar: P. Neelima, N. Sindhura, M. Padma, C.V. Lakshmi, Nugalasindhura

Cilt 4 , Sayı 17 , 2021 , Sayfalar 325-329

Konular:-

Anahtar Kelimeler:C,It expression,Reast carcinoma,TNM stage,Tumor,Luminal A type

Özet: Aims and objectives: To evaluate the c-kit (CD117) expression and its prognostic valueinvasive breast carcinoma and also to correlate its expression with grade of the tumor, TNM staging, ER, PR, Her2/neu & BRCA1 immunomarkers. Materials and methods: Our study was conducted from July 2011 to December 2012 in a tertiary care hospital, during this period we received a total of 80 modified radical mastectomy specimens of which ER, PR, Her2/neu and BRCA1 were done is 29 cases. Clicinopathological factors were evaluated in detail for these cases, C-Kit expression was analyzed by immunohischemistry method using Quick’s score and correlated with grade of the tumor, TNM staging, ER, PR, Her2/neu & BRCA1 markers. Results: Highest incidence of breast carcinoma was noted in 30 to 40 years of age group and 68.9% were below 50 years of age. Majority of the tumors were of high grade and of T2 stage, accounting to 72.5 % and 65.5% respectively, Lymph node metastasis was noted majorly in N2 category (41.3 %) and none showed distant metastasis. On molecular classification, majority of the tumors were of luminal A type followed by triple negative of 41.4% and 20.6 % respectively. 24.2 % of all the cases expressed C-kit among invasive breast carcinoma of no special type, higher grade, high tumor size, Luminal A and triple negative cases of molecular classification. Lack of C-kit expression was observed majorly in less than 50 years of age group, less tumor size &lymph node metastasis, Luminal B and HER2/Neu positive types on molecular classification. Statistical correlation was attained between C- Kit expression and ER, PR negativity and Her2/Neu positivity. Conclusion: C-Kit (CD117) expression needs to be assessed routinely for all invasive breast carcinoma, either negative or positive will have its prognostic and therapeutic implications respectively.


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2021, title={C-KIT expression in breast carcinoma and its correlation with TNM stage, grade and expression of ER, PR, HER2/NEU& BRCA1}, volume={4}, number={325–329}, publisher={International Journal of Health and Clinical Research}, author={P. Neelima,N. Sindhura,M. Padma,C.V. Lakshmi,Nugalasindhura}, year={2021} }
APA
KOPYALA
P. Neelima,N. Sindhura,M. Padma,C.V. Lakshmi,Nugalasindhura. (2021). C-KIT expression in breast carcinoma and its correlation with TNM stage, grade and expression of ER, PR, HER2/NEU& BRCA1 (Vol. 4). Vol. 4. International Journal of Health and Clinical Research.
MLA
KOPYALA
P. Neelima,N. Sindhura,M. Padma,C.V. Lakshmi,Nugalasindhura. C-KIT Expression in Breast Carcinoma and Its Correlation with TNM Stage, Grade and Expression of ER, PR, HER2/NEU& BRCA1. no. 325–329, International Journal of Health and Clinical Research, 2021.